Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
--------
20:13
--------
20:13
Fibrillation - When Ablation is the Way to Go
Dr. Centor discusses the role of ablation in the management of patients with atrial fibrillation with Dr. Peter Zimetbaum.
--------
22:36
--------
22:36
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
--------
29:55
--------
29:55
Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide
Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.
--------
21:11
--------
21:11
Diagnosing Primary Aldosteronism
Dr. Centor discusses the diagnosis of primary aldosteronism with Dr. Jordana Cohen.
Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.
Italia